For 30 years, metastatic urothelial carcinoma was a therapeutic dead end. Platinum-based chemotherapy remained the first-line ...

Over the past five years, annual per capita healthcare expenses have increased by approximately 1 million won ...

Dx&Vx said its subsidiary Avixgen has signed a global licensing agreement worth about 500 billion won ($360.3 million) with a ...

Korea’s first government evaluation of medical imaging tests found that 1,694 institutions submitted about 3.29 million ...

The family of a patient with stage 4 lung cancer recently launched a petition on the National Assembly's platform, pleading ...

A 20-year follow-up study has shown that eradication of Helicobacter pylori is effective in preventing osteoporosis in women ...

CG MedTech, a Korean orthopedic implant research and manufacturing company, posted strong first-half results in 2025 on the ...

Astellas Korea highlighted the clinical impact of its antibody-drug conjugate (ADC) Padcev (ingredient: enfortumab vedotin) ...

With the subcutaneous (SC) version of MSD’s (known as Merck & Co. in the U.S. and Canada) blockbuster Keytruda (pembrolizumab ...

A study has found that high-dose use of inhaled corticosteroids may increase the risk of developing idiopathic pulmonary ...

Leqembi (lecanemab), developed for Alzheimer's disease, the most common form of dementia, is often hailed as a “dream ...

Onconic Therapeutics said its partner Livzon Pharmaceutical Group, the top gastroenterology company in China, has completed ...